•Blog
BlogOur Blog
Insights, updates, and stories from the Srotas Health team. Follow along how we contribute to the future of clinical research.
Featured Research
medRxiv preprint
>90%
accuracy for breast cancer patient eligibility evaluations
<0.5 mins
review time per patient
62.5 Hrs
clinical time saved
Featured PublicationSROTAS IQ validation study•
SROTAS IQ: AI-Based Clinical Trial Matching Validation in Breast Cancer
Our medRxiv preprint reports 90% or greater accuracy in 5 of 10 breast cancer trials, 88% overall eligibility classification accuracy, and automated assessments in under 0.5 minutes per patient.
More from Srotas
Latest Articles
•Blog
A Deep Dive into Using Transformers for Clinical Trial Matching
Read Article•Blog
Unlocking the Power of FHIR for AI-Driven Oncology
Read Article•Blog
Clinical Site Identification with AI: A Data-Driven Revolution
Read Article•Blog
The "Messy Stuff" that Matters in Clinical Research: Navigating Unstructured Data
Read Article•Blog
How Smaller CROs Can Compete in the 2025 Clinical Trials Market
Read Article•Blog
Micro LLMs for Extracting Oncology Data: Efficient, Accurate, and Cost-Effective
Read Article•Blog